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ABSTRACT
As proteomics initiatives mature, the need will arise
for the multiple visualization of proteins and supra-
molecular complexes within their true context, in situ.
Single-stranded DNA and RNA aptamers can be used
for low resolution imaging of cellular receptors and
cytoplasmic proteins by light microscopy (LM).
These techniques, however, cannot be applied to the
imaging of nuclear antigens as these single-stranded
aptamers bind endogenous RNA and DNA with high
affinity. To overcome this problem, we have devel-
oped a novel method for the in situ detection of pro-
teins using double-stranded DNA oligonucleotides.
To demonstrate this system we have utilized the
prokaryotic DNA-binding proteins LacI and TetR as
peptide tags to image fusion proteins in situ using
dsDNA oligonucleotides encoding either the Lac or
Tetoperator.UsingfluorescentandfluorogolddsDNA
oligonucleotides, we localized within the nucleus
a TetR–PML fusion protein within promyelocytic leu-
kaemia protein (PML) bodies by LM and a LacI–SC35
fusion protein within nuclear speckles by correlative
light and electron microscopy (LM/EM). Isolation of
LacI–SC35 was also accomplished by using biotiny-
lated dsDNA and streptavidin sepharose. The use of
dsDNA oligonucleotides should complement existing
aptamer in situ detection techniques by allowing the
multiple detection and localization of nuclear proteins
in situ and at high resolution.
INTRODUCTION
Proteins in cells are generally detected and localized with
antibodies directed against the proteins themselves or to
fused peptide tags (e.g. Flag-tag or HA-tag) (1). Antibodies
can be functionalized with fluorescent molecules or gold par-
ticles for the detection of the proteins by light (LM) and
electron microscopy (EM). To visualize the localization and
dynamics of specific proteins in living cells, natural and engi-
neered fluorescent proteins (FPs) [e.g. green fluorescent pro-
tein (GFP)] have been used as tags (2,3). Both antibodies and
FPs have been attractive reagents for cell biologists because of
their versatility and ease of use, though several limitations
exist with these systems. One limitation is the small repertoire
of bright and spectrally distinct proteins or fluorophores that
are available. In addition, a specific combination of excitation
filter, emission filter and dichroic mirror is required to visua-
lize the fluorescence emission from a particular fluorophore or
combination of fluorophores during epifluorescence micro-
scopy, with the result that detection of three different proteins
is often the practical limit. Furthermore, the in situ detection
of three or more proteins simultaneously, using antibodies
requires that each antibody be produced in a different and
immunologically distinct animal so that secondary antibodies
conjugated to each fluorophore do not cross-hybridize, result-
ing in false-positive detection. FPs cannot be used for EM but
antibodies tagged with electron dense materials do provide the
ability to localize proteins at high spatial resolution. The com-
bination of these techniques via correlative LM and EM has
provided great insight into cellular function by bridging the
resolution gap between observations made by LM and the
ultrastructure of complexes containing particular protein
molecules (4,5). Unfortunately, the practical limit of simulta-
neous protein localization by EM is only two; achieved by
using two different sizes of gold particles, e.g. 5 and 10 nm
gold. In particular, no system currently exists for the multiple
and simultaneous detection of proteins by EM. Thus, as pro-
teomics efforts mature from the cataloguing of proteins within
complexes to the actual localization of these proteins in situ,
new reagents will be needed that can provide for multiple
and simultaneous (multiplex) detection of proteins by both
LM and EM.
Many of the problems faced by cell biologists when ima-
ging proteins in situ are shared by biochemists developing
diagnostic methods for the detection of multiple protein
components in complex biological solutions. Over the past
decade, a technology based on oligonucleotides has been
developed that demonstrates the potential for multiplex
detection of proteins in both solution and in situ. This tech-
nology relies on single-stranded (ss) DNA or RNA oligonu-
cleotides called aptamers, which can bind protein targets with
high affinity (6). However, the use of the term aptamer,
which is derived from the latin root apt (meaning ‘to fit’),
has not been specifically limited to single-stranded RNA and
DNA but has been used to describe any synthetic polymer
that binds a target ligand, including peptides (7). Aptamers
that recognize a specific protein are selected by multiple
rounds of binding, isolation and amplification using a pro-
cedure termed systematic evolution of ligands by exponential
enrichment (SELEX)(8,9). The chemistry for the production
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and functionalization of oligonucleotides is well developed.
Consequently, once aptamers are selected, they can be func-
tionalized using a wide variety of fluorophores, as well as
cobalt or iron paramagnetic particles, gold, radio-isotopes
and biotin. Labelled aptamers have been used much in the
same way as antibodies, for example in ELISAs, sandwich
assays, and Western blotting (10–12). Aptamers have been
selected that bind a number of eukaryotic transcription fac-
tors (13) as well as non-DNA binding proteins such as throm-
bin (14,15). Aptamers are generally much smaller than even
Fab fragments of antibodies (<10 kDa on average compared
with 50 kDa, respectively), indicating that they would exhibit
high penetrance within fixed biological material and should
provide superior spatial resolution when used as probes for
EM (16). In addition, nucleic acid aptamers also provide the
potential for multiplex detection of proteins in situ. Unfortu-
nately, ssDNA and RNA aptamers have a propensity to bind
cellular RNA and DNA with high affinity, precluding their
use as detection reagents for nuclear proteins (16). Therefore,
nucleic acid-based imaging reagents that can be used for high
resolution imaging of nuclear proteins need to be developed.
In this paper we describe a method for the in situ detection and
isolation of proteins that can be used to successfully image
nuclear antigens by LM and EM. This method is based on the
ability of a peptide tag to bind a double-stranded DNA oligo-
nucleotide (dsDNA oligo) with high affinity. As a proof-of-
principle, we have chosen to use two well-known prokaryotic
DNA binding proteins, the Lac repressor (LacI) and the Tet
repressor (TetR) as our peptide tags and the symmetric
dsDNA Lac operator (O-Sym) or the dsDNA Tet operator
(Tet-O) as our detecting oligos. We use these dsDNA oligos to
detect a LacI-tagged splicing factor, SC35 and a TetR-tagged
promyelocytic leukaemia protein (PML). In addition, we use the
O-Sym dsDNA oligo to isolate LacI-tagged SC35 from cell
extracts via biotinylated dsDNA oligos and streptavidin sephar-
ose. Lastly, using fluorescent dsDNA coupled to gold particles
we demonstrate the utility of dsDNA oligos for correlative LM/
EM. Our results demonstrate that LacI-tagged SC35 and TetR-
tagged PML localize adequately to nuclear speckles or PML
nuclear bodies, and that we can detect these proteins in situ using
small (41 bp) dsDNA oligos at nanomolar concentrations.
Furthermore, we can detect both these proteins in the same
cell without cross-hybridization of the detecting oligos, demon-
strating the ability of dsDNA oligos for the multiplex detection
of proteins in situ. Thus, our results provide the first evidence
that dsDNA oligos can be used to localize proteins in situ within
sub-cellular structures at high resolution.
MATERIALS AND METHODS
Vector construction
The mammalian expression vector pGD-Flag-Lac338 and its
derivative pGD-Flag-Lac-SC35 were constructed as follows.
Plasmid pcDNA3.1/His-C (Invitrogen) was cut with HindIII
and Asp718 and ligated to an Asp718/HindIII cut PCR product
(Flag-Lac338) to produce pGD-Flag-Lac338. The Flag-
Lac338 PCR product encodes the amino acid sequence
of the Flag epitope (MDYKDDDDK) fused to the first 338
aminoacids of the LacI and was amplified from the vector
p30SS-GFP-Lac-NLS [generous gift of A. Belmont (17)] using
the following primers, LACFLAG-1 (tgacgtaagcttaggatggac-
tataaagacgatgacgataaaccagtaacgttatacga) and LAC3R-338
(ctataaggtaccgccccctccacttccaccgcccccagaggcggtttgcgtattgg-
gcgcca). To generate pGD-Flag-Lac-SC35, both pGD-Flag-
Lac338 and the vector pBSK-SC35 were first cut with
Asp718, blunt ended with Klenow in the same buffer, followed
by phenol/chlorophorm extraction and precipitation, after
which the DNA was resuspended and digested with BamHI.
The resulting blunt end/BamHI pGD-Flag-Lac338 vector and
the fragment containing the SC35 cDNA from pBSK-SC35
were ligated together. The pBSK-SC35 was generated by sub-
cloning of the human SC35 HindIII fragment from pEGFP-
SC35 (gift of Dr M. Hendzel) into HindIII cut pBlueScript(+)
(Stratagene).
The mammalian expression vector pGD-HA-TET and its
derivative pGD-HA-TET-PML were constructed as follows.
Plasmid pcDNA3.1/His-C (Invitrogen) was cut with HindIII
and Asp718 and ligated to an Asp718/HindIII cut PCR product
(HA-TET) to produce pGD-HA-TET. The HA-TET PCR pro-
duct encodes the amino acid sequence of the haemagglutinin
(HA) epitope (MGYPYDVPDYAG) fused to the TetR and
was amplified from the vector pTET-OFF (Clontech) using
the following primers, TET-HA-1F (gggttttaagcttaccatggga-
tatccctatgatgtgccagactacgcgggaatgtctagattagataaaagt) and
TET-HA-1R (tagattggatccaccgcctcctttaagttgtttttctaatccgca).
To generate pGD-HA-TET-PML, both pGD-HA-TET and
the vector pBSK-PML IV were first cut with BamHI and
EcoRI, after which the linearized DNA fragment containing
the human PML IV gene was gel purified and ligated to the
linearized pGD-HA-TET. pBSK-PML IV was generated by
subcloning the BamHI/EcoRI DNA fragment of the human
PML IV gene from pDsRED-PML (gift of M. Hendzel) into
BamHI/EcoRI digested pBlueScript(+) (Stratagene).
Oligonucleotide synthesis and modification
For construction of functionalized dsDNA oligos recognized by
LacI, two 41 bp single-stranded oligonucleotides were con-
structed encoding the symmetrical Lac operator 19 bp core
sequence O-Sym (18): O-Sym-1 (*gcgtgtgccagaattgtgagcgct-
cacaatttcttgaatct) and O-Sym-2 (*agattcaagaaattgtgagcgctca-
caattctggctcacgc); where * represents a 50 modification with
either biotin, Cy3 or a disulfide group linked via a (CH2)6 spacer
(Sigma). O-Sym-1 and 2 were resuspended to 200 mM and
equal volumes of each oligo were added to a 1/5 volume of 10·
annealingbuffer (50mMTris–HclpH7.5,1MNaCland0.2mM
EDTA). The oligo mixture was then boiled for 4 min at 90C
followed by slow equilibration to room temperature to allow
the annealing of the two O-Sym oligos to produce a 91 mM
solution of the dsDNA O-Sym oligonucleotide.
Similarly, functionalized dsDNA oligos recognized by TetR,
were constructed from the following 41 bp oligonucleotides:
Tet-O-1 (*tcgagtttactccctatcagtgatagagaacgtatgtcgcc) and
Tet-O-2 (*ggcgacatacgttctctatcactgatagggagtaaactcgt); where *
represents a 50 modification with either biotin or Cy5 (Sigma).
These oligonucleotides were annealed as described above to
produce a 91 mM solution of dsDNA Tet-O oligonucleotide.
Fluorogold dsDNA oligo synthesis
The dsDNA oligo consisting of the disulfide-modified O-Sym-1
and Cy3-modified O-Sym-2 was treated with 0.04 M DTT
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(0.17 M Na2HPO4, pH 8.0) for 16 h at room temperature to
cleave the disulfide bond. The thiol by-products and DTT were
removed using a Sephadex column (NAP-5, Amersham Bio-
sciences) equilibrated with 20 mM Na2HPO4, 150 NaCl and
1 mM EDTA, pH 6.5 (conjugation buffer). The dsDNA oligo
was further purified by 70% ethanol precipitation and repeated
washes. The pellet was resuspended in the conjugation buffer
to a concentration of 100 mM. Then, 10 ml (1 nmol) of this
solution was added to 10 nmol of monomaledo-undecagold
reagent (Nanoprobes, Yaphank, NY) in 1 ml of the conjuga-
tion buffer. The mixture was incubated at room temperature
with stirring for 1 h, then incubated at 4C for 16 h. The
functionalized dsDNA oligos were isolated from excess nano-
crystals by ethanol precipitation with excess salmon sperm
DNA, followed by repeated washes. The product was resus-
pended in 10 mM Tris–HCl, 0.1 mM EDTA and 150 mM KCl,
pH 7.5, to achieve a final oligo concentration of 10 mM.
Cell culture and transfection
SK-N-SH cells were cultured according to the American Type
Culture Collection (ATCC) guidelines for each cell line. Cells
were split the day before transfection and 2 · 105 cells were
seeded at 105 cells/ml onto 18 mm square coverslips in 8 or
6 well plates. The following day, cells were transfected with
1–2 mg of pGD-Flag-Lac338 and pGD-TET-PML DNA alone
or combined per well using Lipofectamine 2000 (Invitrogen)
as suggested by the manufacturer.
Protein isolation using dsDNA oligos and
Western analysis
SK-N-SH neuroblastoma cells transfected with either LacI or
LacI–SC35 were lysed by sonication [3 · 30 s at 20% power
using an Ultrasonic Processor (Hert Systems)] in protein iso-
lation buffer-A (PIB-A; 20 mM HEPES pH 7.5, 250 mM KCl,
10% glycerol, 1 mM phenylmethylsulfonyl fluoride (PMSF),
1· Complete protease cocktail (Roche), 1 mM NaF, 40 mM
b-glycerolphosphate). The resulting lysate (PI lysate) was then
centrifuged at 12 000 g for 20 min to remove cellular debris
and pre-cleared by incubation of the supernatant with strepta-
vidin sepharose beads (Invitrogen) for 1 h at 4C followed by
centrifugation at 12 000 g for 5 s to remove the sepharose
beads. The precleared PI lysate was either snap frozen on
dry ice or used immediately for protein isolation. For protein
isolation using dsDNA oligos, streptavidin sepharose was first
pre-incubated with biotinylated O-Sym oligo (100 ml of strep-
tavidin sepharose in 1 ml of PBS containing 500 nM dsDNA
oligo) and then washed 3 times with PIB-A. Then PI lysate
containing 250–500 mg of total protein was incubated with
30–50 ml of streptavidin sepharose beads pre-incubated with
biotinylated O-Sym oligo over night at 4C. Mock protein
isolation (Mock-PI) was carried out using streptavidin sepharose
without oligos. The protein isolated using dsDNA oligos was
then washed 3 times with PIB-A containing 0.5% Triton
X-100 and 2 times with phosphate-buffered saline (PBS)
before being boiled for SDS–PAGE and western transfer.
Western blots were visualized using the SuperSignal West
Pico Chemiluminescent kit (Pierce) as per the manufacturer’s
instructions.
Alternatively, qualitative analysis of the level of purification
of LacI–SC35 by protein isolation using dsDNA oligos, versus
immunoprecipitation using an antibody, was carried out by
SDS–PAGE, followed by Coomassie blue staining of the acry-
lamide gel to visualize the isolated proteins. Briefly, 500–1000
mg of total protein lysate prepared from LacI–SC35 transfected
SK-N-SH, as described above, was first precleared twice by
incubation with 2 · 100 ml of streptavidin sepharose 1 h at 4C.
The precleared lysate was then incubated overnight at 4C
with continuous mixing with either 100 ml of streptavidin
sepharose alone (Mock) or pre-incubated with O-Sym oligo
or 50 ml of Protein G sepharose pre-incubated with 20 mg of
anti-Flag epitope antibody M2 (Sigma) (immunoprecipitation
or IP). In addition, unrelated dsDNA oligo (i.e. TetO)
was added to a concentration of 1 mM to the precleared
lysate during protein isolation to reduce the non-specific co-
purification of other DNA binding proteins. The proteins
isolated by dsDNA oligonucleotides and anti-Flag IP were then
washed 3 times with A-PIB containing 0.5% Triton X-100
and 2 times with PBS before being boiled for SDS–PAGE
followed by staining of the gel by Coomassie blue.
Oligonucleotide hybridization, immunofluorescence
and microscopic imaging of LacI- and
TetR-tagged proteins
Twenty-four to 36 h post transfection cells were fixed in 1–2%
paraformaldehyde in PBS for 5 min. followed by permeabi-
lization in 0.5% Triton X-100 for 5 min at RT. Following
several washes in PBS, cells were then blocked for 20 min
at RT with O-Sym Binding/Blocking (OSB) buffer (10 mM
Tris–HCl pH 7.5, 0.1 mM EDTA, 150 mM KCl, 600 mg/ml of
sheared herring sperm DNA and 200 mg/ml of BSA). Directly
following the blocking step, cells were hybridized for 1–2 h at
37C with the dsDNA O-Sym oligo (labelled with either Cy3,
biotin or both) alone or combined with dsDNA Tet-O oligo
(labelled with either Cy5, biotin or both) in OSB buffer at
a concentration of 50–100 nM. After hybridization with the
O-Sym or Tet-O oligo, coverslips were either washed with
3· PBS and mounted in anti-fade reagent for immediate
immunofluorescence detection or were further processed for
immunofluorescent localization of PML, SC35 or PRP4 kinase
(PRP4K) as described previously (19). Primary antibodies
directed against the Flag epitope (1:250, mouse mAb M2,
Sigma), HA epitope (1:1000, mouse mAb HA.11, Zymed),
PML (1:200, rabbit anti-PML antibody, Chemicon) or
PRP4K [1:100, sheep antibody H143 (18)] were subsequently
detected with secondary antibodies conjugated to Cy5 (1:100,
donkey anti-sheep and anti-mouse Abs) or to Cy3 (1:500,
donkey anti-rabbit Ab) (Jackson Immuno Laboratories). Alter-
natively, following hybridization with a biotinylated O-Sym
oligo, the localization of the LacI- or TetR-fusion protein was
visualized using Cy3-Streptavidin (1:200, Sigma). All fluor-
escence microscopy was performed using a Leica DMR
upright microscope fitted with a Hamamatsu ORCA camera.
Openlab V3.5.1 (Improvision) software was used to collect
fluorescence images. Images were processed using either
ImageJ V1.28 (NIH) or Photoshop 6.0/7.0 (Adobe).
Correlative light and electron spectroscopic imaging
(LM/ESI) of fluorogold dsDNA oligonucleotides
SK-N-SH cells transfected with LacI–SC35 were labelled
using dsDNA oligos as above using fluorogold O-Sym oligos.
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After labelling, cells were post-fixed (8% paraformaldehyde
and 2% glutaraldehyde for 5 min at RT) and subjected to silver
enhancement of the fluorogold dsDNA oligos for 30 min at RT
using a either a silver enhancement kit for LM or EM (Electron
Microscopy Sciences). The EM enhancement was performed
3 times, using fresh enhancement solution each time. The cells
were then dehydrated in a series of graded ethanol washes (30,
50, 70 and 95%) before Quetol 651 resin (EM Science) infil-
tration, curing and sectioning, as described previously (5,20).
Images of cells of interest were collected by both LM, as
described above, and ESI, using a Tecnai 20 TEM (FEI) at
200 kV, equipped with an imaging spectrometer (Gatan).
Elemental maps were generated by dividing the element-
enhanced post-edge image by the pre-edge image following
alignment by cross-correlation. Net ratio elemental maps were
derived from pre- and post-edge images recorded at 120 and
155 eV (LII,III edge) for phosphorus, and at 385 and 415 eV
(K edge) for nitrogen. The recording times required to obtain
the pre-edge and post-edge images are in the range of 10–30 s.
The images were processed using Digital Micrograph (Gatan)
and Photoshop 6.0/7.0 (Adobe).
RESULTS
An overview of protein in situ detection and isolation using
dsDNA oligos is shown in Figure 1. The LacI and the TetR
were chosen as dsDNA-binding protein tags to demonstrate
the ability of dsDNA oligos to image proteins in situ within
cells. A LacI-fusion vector was generated (pGD-Flag-Lac338)
containing the sequence of the first 338 aminoacids of LacI
downstream of a single Flag-tag. This truncated form of the
LacI protein is incapable of forming tetramers and is thought
to form weak dimers in vivo (16). A second DNA construct, a
TetR-fusion vector was constructed (pGD-HA-TET) containing
the full-length Tet repressor downstream of a single HA epi-
tope-tag. The cDNA sequence of any protein can then be cloned
into these vectors for the expression of LacI- or TetR-tagged
fusions of the target protein in mammalian cells. Consequently,
the fusion protein can be localized using a fluorescent labelled
dsDNA oligo specific for the LacI (i.e. O-Sym) or TetR protein
(i.e. TET-O) (see Methods and Materials).
In situ detection of proteins within subnuclear
compartments using dsDNA oligos
To demonstrate the ability of dsDNA oligos (Figure 1A) to
localize proteins in situ, we chose to observe the localization of
the splicing factor protein, SC35. SC35 localizes to well char-
acterized sub-domains within the mammalian nucleus, termed
nuclear speckles at the light level and interchromatin granule
clusters at the ultrastructural level. These structures contain
both RNAs and proteins involved in pre-mRNA splicing and
metabolism (21). We cloned the cDNA sequence encoding the
human SC35 gene into the LacI expression vector to create
pGD-Flag-Lac-SC35. A human neuroblastoma cell line, SK-
N-SH, was transfected with pGD-Flag-Lac-SC35. After 24 h
post transfection, cells were fixed and analysed by immuno-
fluorescence using antibodies directed against the Flag epitope
or with the O-Sym dsDNA oligo (Figure 2A and B). This
localization was compared with that of PRP4 kinase
(PRP4K), an endogenous marker for nuclear speckle domains
(19), by antibody detection (PRP4K, Figure 2A and B). Both
the anti-Flag antibody (Flag, Figure 2A) and the O-Sym oligo
(O-Sym, Figure 2B) could specifically detect cells transfected
Figure 1. In situ detection and isolation of proteins using dsDNA oligonucleotides. (A) Detection of proteins in situ using dsDNA oligos. Cells grown on slides are
fixed and hybridized with fluorescently labelled dsDNA oligos (red or green) that can detect the presence of proteins fused to either LacI (1) or TetR (2). The
fluorescent dsDNA oligos corresponding to the operator sequences for LacI or TetR (green or red, respectively) bind each bacterial fusion protein specifically without
cross hybridizing resulting in the sub-nuclear localization of the tagged proteins by light microscopy. (B) Isolation and detection of proteins in vitro using dsDNA
oligos. Streptavidin-sepharose beads (S) are sequentially incubated with biotinylated dsDNA oligos representing the operator sequences for LacI followed by
incubation with a cell lysate containing LacI fused to a protein of interest (1). After binding the beads are washed and the resulting purified LacI-fusion protein can be
observed by SDS–PAGE. M, marker, IN, input lysate, PI, isolated protein.
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Figure 2. In situ localization of SC35 and PML in human SK-N-SH cells using dsDNA oligonucleotides. (A) Localization of the LacI-tagged SC35 in
paraformaldehyde fixed cells transfected with pGD-Flag-Lac-SC35 using the anti-Flag antibody M2 (Flag, red) or (B) with a Cy3-labelled dsDNA oligo
(O-Sym, red) specific for LacI. PRP4 kinase was also localized as an endogenous marker for splicing speckles by antibody detection (PRP4K, green). Positive
co-localization between PRP4K and LacI-tagged SC35 is demonstrated by a yellow signal in the merged images. The localization of the LacI–SC35 fusion protein
was observed only in transfected cells (see B, O-Sym) and showed complete co-localization with PRP4 kinase (PRP4K, green) in nuclear speckles. (C) Localization
of the TetR-tagged PML in paraformaldehyde fixed cells transfected with pGD-HA-TET-PML using the anti-HA (HA, red) or (D) with a Cy5-labelled dsDNA oligo
(TET-O, red) specific for TetR. Endogenous PML was also localized as a marker for PML nuclear bodies antibody detection (PML, green). Positive co-localization
between PML and TetR-tagged PML is demonstrated by a yellow signal in the merged images. The localization of the TetR–PML fusion protein was observed only
in transfected cells (see C, TET-O) and showed complete co-localization with PML (PML, green) in PML nuclear bodies. (E) Multiple detection and localization
of LacI–SC35 and TetR–PML in cells transfected with pGD-HA-TET-PML and pGD-Flag-Lac338-Sc35. Localization of LacI–SC35 and TetR–PML was
accomplished using Cy3-labelled O-Sym or Cy5-labelled TET-O dsDNA oligos, respectively. TetR–PML and LacI–SC35 do not co-localize [separate red and
green signals (respectively) in merged image], thus demonstrating the utility of dsDNA oligos for the multiplex detection of proteins in situ. DNA was counterstained
with DAPI (blue in merged images). Scale bars = 5 mm.
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with the LacI–SC35 fusion vector. We found that the O-Sym
oligo could be used at concentrations between 50 and 100 nM
for the detection of LacI-fusion proteins within transfected
cells. The distribution of the LacI–SC35 fusion protein was
indistinguishable from that of PRP4K, indicating that the
fusion protein had been targeted correctly to nuclear speckle
domains.
To demonstrate the utility of dsDNA oligonucleotides for
multiplex detection of proteins in situ, we generated a second
fusion protein vector containing PML fused with the Tet
repressor (pGD-HA-TET-PML). The PML protein is a struc-
tural component of PML nuclear bodies implicated in DNA
repair, apoptosis, gene regulation, and tumour suppression
(22–24). PML nuclear bodies are functionally, spatially and
biochemically distinct from nuclear speckles and thus a fusion
protein targeted to this sub-nuclear compartment should not co-
localize with a protein directed to nuclear speckles containing
SC35. SK-N-SH cells were transfected with pGD-HA-TET-
PML alone or in combination with pGD-Flag-Lac-SC35.
After 24 h post transfection, cells were fixed and analysed
by immunofluorescence using antibodies directed against the
HA epitope or with the Tet-O dsDNA oligo (Figure 2C and D).
This localization was compared with that of endogenous
PML, using an anti-PML rabbit polyclonal antibody (PML,
Figure 2C and D). Both anti-HA antibodies (HA, Figure 2A)
and the Tet-O oligo (TET-O, Figure 2D) could specifically
detect cells transfected with the TetR–PML fusion vector.
In addition, dsDNA oligo detection of TetR–PML and
LacI–SC35 was accomplished over a wide range of transient
expression levels, which paralleled or exceeded antibody
detection of the same fusion proteins. Although we did not
quantitate absolute expression on a cell per cell basis, we
estimate the fusion-protein levels to be physiologically rele-
vant in the images shown in Figure 2 based on the nuclear
morphology of these cells in reference to PML bodies and
splicing speckles, which appear normal. The Tet-O oligo
could be used at concentrations between 50 and 100 nM,
thus equalling the sensitivity of O-Sym oligo detection
of LacI-fusion proteins within transfected cells. The TetR–
PML fusion protein localized correctly to PML bodies
as demonstrated by co-localization with endogenous PML
(Figure 2C and D). Unambiguous detection and localization
of TetR–PML and LacI–SC35 was accomplished within the
same cell by hybridization with both dsDNA oligos (Tet-O and
O-Sym, respectively; Figure 2E). As expected, PML nuclear
bodies containing TetR–PML and nuclear speckles containing
LacI–SC35 did not co-localize, demonstrating the ability of
dsDNA oligos to detect multiple proteins within the same cell
without cross-hybridization.
Isolation of the LacI-tagged SC35 protein using
dsDNA oligos
To demonstrate the ability of dsDNA oligos for protein isolation
(Figure 1B), we made whole cell lysates from SK-N-SH cells
transiently expressing either LacI-tagged SC35 or LacI alone.
Thelysateswere thenused inprotein isolationusingbiotinylated
O-Sym dsDNA oligos immobilized on streptavidin sepharose.
The LacI protein also contains an N-terminal Flag-tag, which
was used for western analysis of the LacI–SC35 isolated using
dsDNA oligos (Figure 3). The level of the LacI–SC35 fusion
protein in these lysates was roughly equal to the endogenous
level of SC35 protein (data not shown). Both LacI–SC35 and
LacI alone were isolated by the O-Sym oligo (Lanes 3, 5 of
Figure 3A, respectively) but streptavidin sepharose alone
(Lane 4, Figure 3A) failed to isolate LacI–SC35. The identity
of the LacI–SC35 protein was confirmed by western analysis of
the same blot using the anti-phospho-SR protein monoclonal
antibody mAb 104 (Figure 3B), which detects a number of SR
proteins including SC35 (25). We also carried out a qualitative
comparison between IP using an anti-Flag epitope antibody
and dsDNA oligo isolation of the LacI–SC35 fusion protein
(Figure 3C). Although a comparison of the purity of the
LacI–SC35 protein isolated by IP or dsDNA oligos was pre-
cluded by the relatively small recovery of protein in our experi-
ments, the purity of the IP was compromised by the
co-purification of the immunoglobulin used for IP (Figure 3C,
the band marked by the asterix is the mouse IgG heavy chain).
Figure 3. Isolation of LacI-tagged SC35 from human SK-N-SH cells using
dsDNA oligonucleotides. Total cellular lysates and isolated protein (PI) lysates
were prepared from SK-N-SH cells transiently expressing LacI or LacI-tagged
SC35. The protein isolation of LacI and LacI-tagged SC35 from PI-lysates was
carried out using streptavidin beads pre-incubated with biotinylated dsDNA
oligo specific for LacI (O-Sym). Western analysis of total cellular lysate (1), PI
lysate (2), protein isolated by dsDNA oligos (oligo-PI) (3), and mock oligo-PI
(4) from LacI–SC35 expressing cells, or PI lysate were generated from LacI
expressing cells. Proteins were detected using either anti-Flag (A) or anti-SR
protein (mAb 104) (B) antibodies. In addition, a Coomassie stained SDS–
PAGE gel is shown as a qualitative comparison of dsDNA oligo PI versus
immunopreciptiation (IP) using an anti-Flag antibody (C). In panel C: lane M,
protein molecular weight marker; lane 1, 40 mg of total lysate; lane 2, oligo-PI;
lane 3, Mock oligo-PI; and lane 4, anti-Flag IP. The asterisk marks the position
of co-purifying immunoglobulin (i.e. heavy chain is shown) in the Flag-IP. The
black arrows indicate the position of LacI–SC35 in panels B,C. Approximately
250–500 mg or 500–1000 mg of total protein lysate was used for western or
Coomassie SDS–PAGE analysis, respectively.
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Correlative light and electron spectroscopic imaging
using fluorogold dsDNA oligos
In order to demonstrate the utility of our dsDNA oligo detec-
tion system for correlative fluorescence and EM, a fluorogold
dsDNA oligo was generated. This oligo contains a Cy3 moiety
on the 50 end of one strand of the O-Sym oligo for detection in
the fluorescence microscope, and an undecagold nanoparticle
on the 50 end of the complementary strand for detection by
EM. The nanogold label by itself is too small to be detected by
conventional transmission EM, but can easily be enlarged for
detection by silver enhancement. To illustrate the use of the
doubly labelled fluorogold oligo for detection by correlative
LM and EM, SK-N-SH neuroblastoma cells were transfected
with pGD-Flag-Lac-SC35 and detected with the fluorogold
oligo as shown in Figure 4A. The transfected cell (left
panel) exhibited the distinct speckled pattern of the SC35
domain (21), illustrating the effectiveness of the fluorescent
component of the oligo. We confirmed the presence of gold
in the oligo by performing an extended silver enhancement on
the sample and bright field imaging by the light microscope
[Figure 4A (right panel)]. Whereas transfected cells are
heavily labelled with silver, untransfected cells have only
background levels of silver deposition.
Figure 4. Correlative lightandelectronspectroscopic imaging(LM/ESI)ofSK-N-SHcellsexpressingLacI-taggedSC35usingfluorogolddsDNAoligos.Detectionof
nuclear speckles (arrow) via the Cy3 fluorophore (A, left panel), and confirmation of gold conjugation to the dsDNA oligo through silver enhancement (A, right panel).
Untransfected cells (arrowhead) contain background levels of silver deposition. Scale bar = 200 nm. (B) Overlay of fluorescence and low magnification ESI
micrographs collected at 155 eV. With two rounds of the silver enhancement using a LM enhancement kit (B, left panel), the silver particles are visible as bright
spots. The right panel is an overlay image of a nucleus containing EM-enhanced gold. Scale bar=2mm. An area corresponding to an IGC, as defined by a box in the left
panel is analysed at high resolution, and maps of phosphorus (C, red panel) and nitrogen (C, green panel) show the ultrastructure of the IGC region, which is low in
phosphorus content and contains protein-based fibrous structures. The fluorogold oligo localization is indicated with silver-enhanced gold particles false-coloured in
white. The compositemap (D, left panel) illustrates the position of the IGC relative to chromatin (Ch, yellow) and the nucleolus (Nu, yellow-green). The silver particles
in the interior of the IGC are labelled with arrowheads, whereas those proximal to the neighbouring chromatin are indicated by arrows. The composite map (D, right
panel) of the EM-enhanced nucleus (B, right panel) contains smaller but uniform silver particles, as indicated by the arrows and arrowheads. Scale bar = 5 mm.
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Correlative fluorescence and ESI (5) was then carried out on
LacI–SC35 transfected cells (see Materials and Methods).
Physical sections were first imaged with the fluorescence
microscope to detect the Cy3 label bound to the oligo.
The section containing the same cell was then imaged in the
electron microscope. We chose to use ESI, rather than con-
ventional transmission EM because of its advantages in
identifying protein- versus nucleic acid-based components
in and around nuclear speckle domains (also known as inter-
chromatin granule clusters or IGCs). An overlay of fluores-
cence microscope images and low magnification energy
filtered images were obtained (Figure 4B). Only cells that
expressed the LacI–SC35 fusion protein had detectable sil-
ver-enhanced fluorogold oligo and this signal was restricted
to regions of Cy3 signal in the correlative fluorescence image
(Figure 4B). A phosphorus map [Figure 4C (left panel)] and a
nitrogen map [Figure 4C (right)] can be used to identify
condensed chromatin, the nucleolus and the IGC domain.
The fluorogold oligo was heavily enhanced with silver, result-
ing in large accumulation of silver, shown as white blobs
(Figure 4C). Careful examination of the low magnification
image also revealed the large silver clusters [Figure 4B
(left panel)]. The composite of the phosphorus and nitrogen
images [Figure 4D (left panel)] shows chromatin (yellow
regions) and a morphologically dense region, corresponding
to the nucleolus (yellow-green). The green structures, includ-
ing the fibrous material in the IGC signifies protein-based
structures. The area delineated by a dashed line corresponds
to the region occupied by the IGC. The gold particles within
the interior of this domain are highlighted by arrowheads,
whereas the particles having close proximity to neighbouring
chromatin are highlighted with arrows.
In a second nucleus presented, the gold particles were
enhanced to a lesser degree [Figure 4B (right panel)], and
imaged by phosphorus and nitrogen mapping at higher mag-
nification [Figure 4D (composite shown in right panel)]. The
silver particles are much smaller but more uniform, thus more
suitable for ultrastructural characterization of protein compo-
nents. Fluorogold dsDNA oligos revealing the presence of
SC35 in the core of the IGC are indicated with arrowheads,
whereas oligos revealing the presence of SC35 at the
IGC:chromatin boundary are indicated with arrows.
DISCUSSION
In the present study, we have demonstrated the ability of
synthetic dsDNA oligos, to detect proteins in situ within mam-
malian cells. As proof-of-principle, we used a dsDNA oligo
based on the symmetrical operator of the LacI repressor (O-
Sym) to successfully identify the presence of the LacI–SC35
fusion protein in nuclear speckles (Figure 2). Qualitative com-
parison indicate that in situ detection with dsDNA oligos is at
least as sensitive if not superior to antibody detection of the
same fusion protein using the anti-Flag antibody. Our dsDNA
oligo in situ detection protocol is rapid and flexible, being
90 min shorter than conventional immuno-detection using
primary and secondary antibodies, and easily combined with
the standard antibody detection protocol without extensive
sample processing. These results are in sharp contrast to a
recent failure to specifically localize GFP in both fungi and
mammalian cells using a ssDNA aptamer selected in vitro to
bind GFP (16). Two other studies have shown the ability of
fluorescently tagged, ssDNA aptamers to image endogenous
proteins by LM either as cell surface markers [pigpen endothe-
lial protein (26)] or cytoplasmic antigens [cytoplasmic ERK2
(27)]. However, to date there are no studies describing the high
resolution imaging of subnuclear antigens, most likely due to
the propensity of ssDNA aptamers to non specifically bind
RNA within the nucleus (16). Therefore, an important con-
clusion from our study is that aptamers that are at least in part
double stranded could provide a simple means of circumvent-
ing the propensity of ssRNA or DNA aptamers to bind endo-
genous RNA during the in situ detection of nuclear antigens. In
addition, we have also successfully detected cytoplasmic
fusion proteins using our dsDNA oligo in situ detection pro-
tocol, suggesting that the technique need not be limited to the
detection of nuclear antigens (Klip, Dellaire and Bazett-Jones,
unpublished observations). Thus, we present both the first
peptide-oligo tag system for in situ detection and the first
demonstration that double-stranded nucleic acids can be
used to image proteins in situ at high resolution within sub-
nuclear compartments of mammalian cells. Futhermore, our
system is the first oligonucleotides-based system to demon-
strate the ability for multiplex detection of proteins in situ
(Figure 2).
Both the O-Sym and Tet-O dsDNA oligos were routinely
used at concentrations in the 50–100 nM range to successfully
detect LacI or TetR-tagged proteins (respectively) in situ. The
reported affinity of the Lac repressor for the O-Sym operator in
solution is much higher; binding constants have been reported
in the 1–10 nM range for the dimeric form of LacI (28). The
requirement for fixation before in situ detection may limit
conformational changes in the LacI or TetR protein required
to bind their operators with optimum efficiency. Supporting
this hypothesis, longer fixation times or higher concentrations
of fixative resulted in the progressive reduction in O-Sym
detection sensitivity (data not shown). Nonetheless, the
observed optimum binding concentration of both the
O-Sym and TetR operator is in the same range as the published
binding constants of many protein specific nucleic acid apta-
mers [i.e. in the 10 nM–10 mM range (29)]. Thus, we believe
that beyond the detection of DNA binding protein tags, endo-
genous nuclear proteins could be detected in situ using ssDNA
aptamers that are at least partially double stranded in nature
and have affinities at or <100 nM for their ligand.
Transcription factors and prokaryotic DNA binding proteins
such as LacI have been traditionally purified using dsDNAs
encoding the binding sites of these proteins bound to sepharose
(30). Similary, using our dsDNA oligo-peptide tag system we
were able to isolate transiently expressed LacI-tagged SC35
from total cell lysate using biotinylated dsDNA oligos encod-
ing the Lac Operator bound to streptavidin sepharose (Figure 3).
In addition, ssDNA aptamers directed against recombinant
proteins have been used in aptamer-affinity chromatography
(31). For the purification of proteins for proteomics analysis
such as mass spectrometry, it is preferred if the protein com-
plexes of interest are isolated under native conditions. For
example, the tandem affinity purification (TAP) tag system,
which utilizes tandem IgG binding domains from protein
A and the calmodulin binding peptide, allows the gentle
elution of proteins under native conditions using ethylenebis
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(oxyethylenenitrilo tetraacetic acid) (EGTA) (32). In our
dsDNA-peptide tag system, which is based on TetR or LacI
fusion proteins, gentle elution from the affinity column may be
accomplished by the addition of heparin (33) to the column or
by using small metabolites such as tetracycline (34) or iso-
propyl b-D-thiogalactoside (IPTG) (30), respectively. In par-
ticular, affinity purification of proteins by nucleic acid based
chromatography may provide a preferred means of isolation of
recombinant proteins for therapeutic use, as antibody-based
chromatography runs the risk of the introduction of antibody
fragments that may induce an undesirable antigenic response
in the patient (e.g. Figure 3C). Thus, although similar to pep-
tide-tag systems in the detection and isolation of proteins using
antibodies (e.g. Flag or HA epitope tag), protein isolation
using dsDNA oligos may provide an ideal mode of recombi-
nant protein purification when contamination by antibody
fragments is undesirable, such as during protein isolation
for mass spectrometry analysis or therapeutic use.
Another advantage of nucleic acids as detection reagents
over antibodies is that their synthesis is rapid and the position
and stoichiometry of the chemical modification can be con-
trolled. In addition, nucleic acids can be coupled with a variety
of moieties during synthesis, including reactive thiols, amines,
paramagnetic beads, fluorophores and biotin. Although we
used fluorescent, biotinylated and gold-modified oligonucleo-
tides for LM it would be possible to directly couple other
moieties more useful for protein purification or ESI such as
paramagnetic particles or metal complexes. In particular, the
use of dsDNA oligos allows the detecting molecule to be easily
functionalized at four independent sites during oligosynthesis
(i.e. at the 30 and 50 of each DNA strand). In addition, further
functional diversity could be accomplished by the direct cou-
pling of peptides with desirable properties to the oligo, such as
specific reactive groups or side chains (e.g. additional amine
groups via poly-lysine). Thus, it should be possible to create
pluri-functional oligos for use with our dsDNA oligo technol-
ogy. For example, in the present study we created a pluri-
functional dsDNA oligo by coupling a fluorophore on one
DNA strand and a nanogold particle to the complementary
DNA strand. The resulting dsDNA fluorogold oligo was then
used for correlative LM (through the fluorophore) and EM
(through post-detection silver enhancement of the gold
moiety) (Figure 4).
Lac repressor is the prototype of a large family of prokar-
yotic helix–turn–helix (HTH) DNA binding proteins, the
sequences of which are available for over 25 members includ-
ing the fructose repressor (FruR), the purine repressor (PurR),
and the galactose repressor (GalR) (35). In addition, the TetR,
AraC, MerR, and MarR families of DNA binding proteins
involved in multi-drug transport and resistance in prokaryotes
provide additional examples of HTH-containing DNA binding
proteins that bind specific operator sequences (36). Several of
these proteins including TetR, BmrR, QacR, and EmrR have
been studied extensively both biochemically and by X-ray
crystallography.
Beyond the sheer number of examples, prokaryotic DNA
binding proteins provide several advantages as peptide tags for
in situ detection of epitope tagged-proteins in mammalian
cells. First, many prokaryotic DNA binding proteins have
evolved as components of regulatory operon systems that
sense the presence of small molecules and metabolites.
These small molecules modulate the binding of such proteins
to their DNA operator sequences through binding to regulatory
domains within these transcription factors and repressors. For
example, IPTG can reduce the affinity of LacI for its operator
in a dose-dependent manner (37). Similarly for TetR, the
presence of tetracycline modulates the interaction of TetR
with its operator (34). Thus, it may be possible to modulate
the sensitivity of in situ detection by dsDNA oligos and as
mentioned above, allow a gentle method of protein elution
during purification of recombinant proteins using these oligos.
Lastly, because of the evolutionary distance between prokar-
yotes and higher eukaryotes such as mammals, the existence of
high affinity operator sequences within the mammalian gen-
ome would be unlikely, thus fusion proteins encoding these
prokaryotic peptides are less likely to mislocalize by binding
to genomic sequences. Taken together, these and other pro-
karyotic DNA binding proteins present a wealth of potential
dsDNA oligo-peptide tag pairs for protein isolation and in situ
detection using dsDNA oligos. Collectively, dsDNA oligo and
aptamer in situ detection (Aptamer-ID) techniques represent a
technology that could provide the means for massive parallel
detection and localization of proteins in vitro or in situ by LM
and EM. Using our knowledge of dsDNA oligo detection, we
are currently evaluating modifications of the SELEX proce-
dure to generate DNA aptamers that can be successfully used
for Aptamer-ID of a wide range of cellular antigens.
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